Overview

Cardiac Arrhythmia Suppression Trial (CAST)

Status:
Completed

Trial end date:
1998-03-01

Target enrollment:

Participant gender:

Summary

To determine whether drug treatment of asymptomatic ventricular arrhythmias in post-myocardial infarction patients reduced the incidence of sudden cardiac death and total mortality.

Phase:

Phase 3

Details

Lead Sponsor:

National Heart, Lung, and Blood Institute (NHLBI)

Treatments:

Encainide
Flecainide
Moricizine